Candidate: Sylvia Becker, MD, MPH is an NRSA-Primary Care Research Fellow in the Department of Family Medicine at the University of North Carolina at Chapel Hill (UNC). Career Development Plan: the candidate Will conduct mentored research and strengthen vital knowledge in global health research. The candidate will be positioned to become leader in vaccine effectiveness in the developing world. Immediate Objective: to acquire expertise in infectious disease epidemiology and vaccine effectiveness;to assess the effectiveness ofthe rotavirus vaccine in a developing world setting. Long-term Objective: to provide evidence on vaccine effectiveness for developing world decision makers.
Specific Aims : 1) Determine the effectiveness ofthe rotavirus vaccine in the primary care setting. 2) Characterize the circulating genotypes of the virus following UIRI implementation. 3) Determine the effect of UIRI on the childhood diarrhea incidence rate in a community. Research Methods:
In Aim 1, we will a case control design to determine the vaccine's effectiveness in reducing primary care visits among children for rotavirus diarrhea at eight primary care centers in Leon, Nicaragua.
In Aim 2, we will characterize the genotypes among all rotavirus-positive stool samples collected in Aim 1 and explore whether type replacement may be occurring.
In Aim 3, we will measure the diarrhea incidence rate among children in the community using a population-based sample provided by an existing Surveillance System based at University of Nicaragua, Leon (UNAN) and compare to the incidence prior to universal rotavirus immunization. Environment: we will work with eight primary care centers in Leon that have a long history of collaboration with members of the research team. Laboratory studies for Aim 1 will be carried out in a laboratory at UNAN while those for Aim 2 will be carried out at the CDC.
Aim 3 will make use of an existing Surveillance System that has an international reputation for the quality of its research. Database management is within this Surveillance System. Mentorship: primary mentorship at the UNC will be provided by epidemiologist and infectious disease specialist, David J. Weber, MD, MPH. Primary mentorship at UNAN will be provided by Felix Espinoza, MD, PhD (Aims 1 and 2) and Rodolfo Peria, MD, PhD (Aim 3). Additional mentorship is provided by leaders in rotavirus epidemiology and vaccine effectiveness, Drs. Umesh Parashar and Manish Patel, by medical geographer, Micheal Emch, PhD, by biostatistician, Michael Hudgens, PhD, by vaccine epidemiologist Jennifer Smith, PhD, MPH, and by gastroenterologist, Douglas Morgan, MD, MPH, who has led the UNC-UNAN research collaboration.

Public Health Relevance

We have the unique opportunity in Leon, Nicaragua to determine the effect of UIRI on the primary care and community levels. At the end of the proposed study, we would provide needed information to others in the developing world who are currently considering adding rotavirus vaccines to their vaccine armamentarium.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01TW008401-04
Application #
8322101
Study Section
Special Emphasis Panel (ZRG1-ICP2-B (51))
Program Officer
Jessup, Christine
Project Start
2009-09-21
Project End
2013-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
4
Fiscal Year
2012
Total Cost
$126,201
Indirect Cost
$9,225
Name
University of North Carolina Chapel Hill
Department
Family Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Bucardo, Filemón; Reyes, Yaoska; Becker-Dreps, Sylvia et al. (2017) Pediatric norovirus GII.4 infections in Nicaragua, 1999-2015. Infect Genet Evol 55:305-312
Becker-Dreps, S; Cuthbertson, C C; Bucardo, F et al. (2017) Environmental factors associated with childhood norovirus diarrhoea in León, Nicaragua. Epidemiol Infect 145:1597-1605
Becker-Dreps, Sylvia; Vilchez, Samuel; Velasquez, Daniel et al. (2015) Rotavirus-specific IgG antibodies from mothers' serum may inhibit infant immune responses to the pentavalent rotavirus vaccine. Pediatr Infect Dis J 34:115-6
Becker-Dreps, Sylvia; Zambrana, Luis Enrique; Reyes, Daniel et al. (2014) Household management of childhood diarrhoea: a population-based study in Nicaragua. J Health Popul Nutr 32:149-54
Panozzo, Catherine A; Becker-Dreps, Sylvia; Pate, Virginia et al. (2014) Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010. Am J Epidemiol 179:895-909
Becker-Dreps, Sylvia; Bucardo, Filemon; Vilchez, Samuel et al. (2014) Etiology of childhood diarrhea after rotavirus vaccine introduction: a prospective, population-based study in Nicaragua. Pediatr Infect Dis J 33:1156-63
Vilchez, Samuel; Becker-Dreps, Sylvia; Amaya, Erick et al. (2014) Characterization of enterotoxigenic Escherichia coli strains isolated from Nicaraguan children in hospital, primary care and community settings. J Med Microbiol 63:729-34
Panozzo, Catherine A; Becker-Dreps, Sylvia; Pate, Virginia et al. (2013) Patterns of rotavirus vaccine uptake and use in privately-insured US infants, 2006-2010. PLoS One 8:e73825
McGrath, Leah J; Becker-Dreps, Sylvia; Pate, Virginia et al. (2013) Trends in antibiotic treatment of acute otitis media and treatment failure in children, 2000-2011. PLoS One 8:e81210
Becker-Dreps, Sylvia; Meléndez, Marlon; Liu, Lan et al. (2013) Community diarrhea incidence before and after rotavirus vaccine introduction in Nicaragua. Am J Trop Med Hyg 89:246-50

Showing the most recent 10 out of 15 publications